A year ago, Blue Shield of California announced that it would move on from a traditional pharmacy benefit management relationship with CVS’ Caremark and instead adopt a new model that leans on mult | The insurer is making one of its first major moves as part of the Pharmacy Care Reimagined model.
A medical expert discusses the key aspects of Lambert-Eaton Myasthenic Syndrome (LEMS) in the context of small cell lung cancer (SCLC), including its differential diagnosis,…
WEDNESDAY, Dec. 18, 2024 (HealthDay News) — The U.S. Food and Drug Administration (FDA) has issued its most serious warning — a black-box warning —…
Where are my robot friends?
TUESDAY, Dec. 17, 2024 (HealthDay News) — The U.S. Preventive Services Task Force (USPSTF) recommends against vitamin D supplementation, with or without calciu
The BEACON system converts important safety information from text to voice and delivers it over the radio within minutes of being issued.
MONDAY, Dec. 16, 2024 (HealthDay News) — More young people around the world are falling prey to colon cancer, a new study shows.Colon cancer rates…
An Institute for Accountable Care report says hospitals could lose an average of $500 per episode of covered services — but the forecast varies widely.
The FDA has cleared Eli Lilly’s obesity drug Zepbound as the first treatment for obstructive sleep apnea in the U.S.
ACP Gastroenterology Monthly delivers a monthly summary of news in gastroenterology and hepatology, including the latest research, clinical guidelines, and FDA drug actions.
Revisit the listened to audio and podcasts at JAMA and the JAMA Network in 2024.
